Sperling Prostate Center

Sperling Prostate Center Interventional uroradiology specializing in the diagnosis and treatment of prostate conditions incl

Dr. Dan Sperling is a leader in the detection of prostate tumors through the use of image-guided technology. He specializes in Magnetic Resonance Imaging (MRI) which he uses for tumor detection, targeted biospies (MRI-Guided Biopsy; MRI/Ultrasound Fusion Biopsy), prostate mapping,and treatment planning. Dr. Sperling is also a recognized pioneer in the field of MRI-Guided prostate treatment including the revolutionary new MRI-Guided Prostate Laser Ablation procedure he helped to develop.

For staging prostate cancer patients (screening for cancer spread) with unfavorable intermediate disease, PSMA-PET scans...
01/15/2026

For staging prostate cancer patients (screening for cancer spread) with unfavorable intermediate disease, PSMA-PET scans outperform conventional bone and CT scans.

Learn more at:

Less than half of patients with unfavorable irPCa and approximately one-third of those with favorable irPCa underwent distant staging. Positive findings were rare, especially with conventional imaging. Therefore, conventional staging might be safely omitted in irPCa, while PSMA PET/CT may be conside...

Confused about whether fusion guidance is truly “MRI-guided”? Learn the important difference between real-time MRI vs. f...
01/15/2026

Confused about whether fusion guidance is truly “MRI-guided”? Learn the important difference between real-time MRI vs. fusion for guiding focal treatment.

Study finds that real time in-bore MRI targeted biopsy has a higher rate for detecting clinically significant prostate cancer than fusion targeted biopsy.

What happens when a doctor finds out he has prostate cancer, gets treated, then deals with side effects? Read the true f...
12/03/2025

What happens when a doctor finds out he has prostate cancer, gets treated, then deals with side effects? Read the true first-person account here.

A physiatrist diagnosed with prostate cancer shares his story of recovery, arguing that pelvic floor rehabilitation must become standard care to address incontinence and restore patient dignity. Learn more.

A large British study is testing a new AI-powered “one day diagnosis” so men with a suspicious MRI can be immediately pr...
11/27/2025

A large British study is testing a new AI-powered “one day diagnosis” so men with a suspicious MRI can be immediately prioritized for further diagnostics.

AI will be used to interpret MRI scans for men suspected of having the disease, helping to spot lesions within minutes

Did you know? An elevated PSA doesn’t automatically mean cancer. mpMRI can help clarify what’s really happening before d...
11/20/2025

Did you know? An elevated PSA doesn’t automatically mean cancer. mpMRI can help clarify what’s really happening before decisions about biopsy or treatment are made.

For decades, prostate cancer screening relied almost entirely on the PSA blood test — often followed by a random biopsy if the level was high. That approach saved lives but also led to unnecessary biopsies and missed aggressive cancers. Today, that’s changing dramatically thanks to one major adv...

💊 The FDA has fast-tracked a new oral drug that may offer improved cancer control for patients with metastatic prostate ...
11/13/2025

💊 The FDA has fast-tracked a new oral drug that may offer improved cancer control for patients with metastatic prostate cancer that no longer responds to hormones.

If you are ready to make an appointment, select a button on the right. If you have questions about MD Anderson’s appointment process, our information page may be the best place to start.

Could something as simple as a daily multivitamin help lower the chances of prostate cancer returning? New research poin...
11/06/2025

Could something as simple as a daily multivitamin help lower the chances of prostate cancer returning? New research points to a potential benefit – especially for men with more aggressive cases.

A recent study brings evidence to light that multivitamin use after prostate cancer treatment may lower the chances of recurrence.

Urine spermine is gaining attention as a noninvasive biomarker for prostate cancer. Studies show that when combined with...
10/29/2025

Urine spermine is gaining attention as a noninvasive biomarker for prostate cancer. Studies show that when combined with PSA and MRI, it can accurately identify high-grade disease while reducing unnecessary biopsies.

Recent evidence suggests that a compound called spermine, which can be measured in a urine test, predicts high grade prostate cancer and also identifies which men can avoid a biopsy.

Not all prostate biopsies are created equal ❌ In-bore MRI guidance offers a safer, more accurate way to detect significa...
10/23/2025

Not all prostate biopsies are created equal ❌ In-bore MRI guidance offers a safer, more accurate way to detect significant prostate cancer, minimizing risks while maximizing results.

Comparison studies show that real time in-bore MRI guided biopsy is superior in diagnostic accuracy over fusion or cognitive guidance.

🔎 Active surveillance helps men avoid overtreatment, but how often should tests and scans be done? New research suggests...
10/15/2025

🔎 Active surveillance helps men avoid overtreatment, but how often should tests and scans be done? New research suggests genetics may hold the answer.

A polygenic risk score may assist in matching Active Surveillance to each patient’s need.

Should Gleason 3+3 prostate cancer keep the name ‘cancer’? Experts weigh in on whether this low-risk condition deserves ...
10/08/2025

Should Gleason 3+3 prostate cancer keep the name ‘cancer’? Experts weigh in on whether this low-risk condition deserves a new label.

What’s in a name? Gleason 3+3 is the subject of a growing debate: indolent condition or true cancer? Here’s what patients need to know.

📊 The numbers are in — and they’re hard to ignore. A new study of over 500,000 men shows a 15% higher risk of death when...
10/01/2025

📊 The numbers are in — and they’re hard to ignore. A new study of over 500,000 men shows a 15% higher risk of death when PSA screening is skipped.

Veterans Administration facilities that practice greater rates of annual PSA screening have lower rates of men being diagnosed with metastatic prostate cancer.

Address

4205 West Atlantic Avenue Building D
Delray Beach, FL
33445

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30am

Telephone

+15612201270

Website

Alerts

Be the first to know and let us send you an email when Sperling Prostate Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Sperling Prostate Center:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

Dr. Dan Sperling is a leader in the detection of prostate tumors through the use of image-guided technology. He specializes in Magnetic Resonance Imaging (MRI) which he uses for tumor detection, targeted biospies (MRI-Guided Biopsy; MRI/Ultrasound Fusion Biopsy), prostate mapping,and treatment planning.

Dr. Sperling is also a recognized pioneer in the field of MRI-Guided prostate treatment including the revolutionary new MRI-Guided Prostate Laser Ablation procedure he helped to develop.